- Home
- TNGX vs TALKW Comparison
TNGX vs TALKW Comparison
Compare TNGX & TALKW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- TALKW
- Stock Information
- Founded
- TNGX 2014
- TALKW 2012
- Country
- TNGX United States
- TALKW United States
- Employees
- TNGX N/A
- TALKW 521
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- TALKW Medical/Nursing Services
- Sector
- TNGX Health Care
- TALKW Health Care
- Exchange
- TNGX Nasdaq
- TALKW Nasdaq
- Market Cap
- TNGX 351.2M
- TALKW N/A
- IPO Year
- TNGX N/A
- TALKW N/A
- Fundamental
- Price
- TNGX $5.88
- TALKW $0.06
- Analyst Decision
- TNGX Strong Buy
- TALKW
- Analyst Count
- TNGX 6
- TALKW 0
- Target Price
- TNGX $12.20
- TALKW N/A
- AVG Volume (30 Days)
- TNGX 2.6M
- TALKW 64.2K
- Earning Date
- TNGX 08-06-2025
- TALKW 02-20-2025
- Dividend Yield
- TNGX N/A
- TALKW N/A
- EPS Growth
- TNGX N/A
- TALKW N/A
- EPS
- TNGX N/A
- TALKW N/A
- Revenue
- TNGX $40,990,000.00
- TALKW $181,291,000.00
- Revenue This Year
- TNGX N/A
- TALKW N/A
- Revenue Next Year
- TNGX N/A
- TALKW N/A
- P/E Ratio
- TNGX N/A
- TALKW N/A
- Revenue Growth
- TNGX 10.09
- TALKW 31.50
- 52 Week Low
- TNGX $1.03
- TALKW $0.20
- 52 Week High
- TNGX $12.02
- TALKW $0.24
- Technical
- Relative Strength Index (RSI)
- TNGX 73.28
- TALKW N/A
- Support Level
- TNGX $5.75
- TALKW N/A
- Resistance Level
- TNGX $6.40
- TALKW N/A
- Average True Range (ATR)
- TNGX 0.50
- TALKW 0.00
- MACD
- TNGX -0.03
- TALKW 0.00
- Stochastic Oscillator
- TNGX 83.80
- TALKW 0.00
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
About TALKW Talkspace Inc. Warrant
Talkspace Inc is a behavioral healthcare company offering access to licensed therapists, psychologists, and psychiatrists through its technology platform. It serves clients including health plans, enterprises, and individual subscribers. Therapists address various mental health conditions, while psychiatrists cater to a higher acuity demographic. Revenue stems from payor and direct-to-enterprise clients, with contracts lasting one to three years. The majority of the Company's operations and revenues are based in the United States.